Nuveen Small Cap Growth Opp C
Name
As of 08/19/2022Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
-22.2%
1 yr return
-23.6%
3 Yr Avg Return
11.6%
5 Yr Avg Return
9.9%
Net Assets
$185 M
Holdings in Top 10
20.0%
52 WEEK LOW AND HIGH
$12.4
$10.28
$24.59
Expenses
OPERATING FEES
Expense Ratio 1.96%
SALES FEES
Front Load N/A
Deferred Load 1.00%
TRADING FEES
Turnover 97.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$3,000
IRA
$2,500
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 08/19/2022Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
FMPCX - Profile
Distributions
- YTD Total Return -22.2%
- 3 Yr Annualized Total Return 11.6%
- 5 Yr Annualized Total Return 9.9%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -1.62%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameNuveen Small Cap Growth Opportunities Fund
-
Fund Family NameNuveen
-
Inception DateSep 24, 2001
-
Shares OutstandingN/A
-
Share ClassC
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerJon Loth
Fund Description
Under normal market conditions, the Fund invests at least 80% of the sum of its net assets and the amount of any borrowings for investment purposes in common stocks of small-capitalization companies. Small-capitalization companies are defined as companies that have market capitalizations within the market capitalization range of the companies in the Russell 2000® Index on the last business day of the month in which its most recent reconstitution was completed. Reconstitution of the index currently is completed in June of each year. On June 30, 2021, the range of the index was $76 million to $29.1 billion.
In selecting stocks, the Fund’s sub-adviser invests in companies that it believes exhibit the potential for superior growth based on factors such as above-average growth in revenue and earnings, strong competitive position, strong management, and sound financial condition. The Fund’s sub-adviser will generally sell a stock if the stock hits its price target, the company’s fundamentals or competitive position significantly deteriorate, or if a better alternative exists in the marketplace.
The Fund may invest up to 15% of its total assets in non-dollar denominated equity securities of non-U.S. issuers. In addition, the Fund may invest up to 25% of its assets, collectively, in non-dollar denominated equity securities of non-U.S. issuers and in dollar-denominated equity securities of non-U.S. issuers that are either listed on a U.S. stock exchange or represented by depositary receipts that may or may not be sponsored by a domestic bank. Up to 15% of the Fund’s total assets may be invested in equity securities of emerging market issuers.
The Fund may utilize options, futures contracts, options on futures contracts, and forward foreign currency exchange contracts (“derivatives”). The Fund may use these derivatives to manage market or business risk, enhance the Fund’s return, or hedge against adverse movements in currency exchange rates.
FMPCX - Performance
Return Ranking - Trailing
| Period | FMPCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -22.2% | -51.4% | 624.8% | 66.51% |
| 1 Yr | -23.6% | -63.8% | 60.0% | 58.98% |
| 3 Yr | 11.6%* | -20.6% | 40.7% | 21.82% |
| 5 Yr | 9.9%* | -14.3% | 30.8% | 51.96% |
| 10 Yr | 10.8%* | -7.0% | 20.0% | 69.35% |
* Annualized
Return Ranking - Calendar
| Period | FMPCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | -22.3% | -98.2% | 781.7% | 88.31% |
| 2022 | 22.8% | -63.0% | 340.3% | 72.42% |
| 2021 | 28.6% | -9.1% | 48.3% | 21.01% |
| 2020 | -25.3% | -76.3% | 13.6% | 77.30% |
| 2019 | -1.7% | -34.7% | 37.0% | 94.07% |
Total Return Ranking - Trailing
| Period | FMPCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -22.2% | -67.4% | 624.8% | 63.30% |
| 1 Yr | -24.1% | -64.1% | 60.0% | 57.96% |
| 3 Yr | 11.6%* | -22.2% | 40.7% | 20.53% |
| 5 Yr | 9.9%* | -15.3% | 30.8% | 50.68% |
| 10 Yr | 10.8%* | -7.6% | 20.0% | 67.79% |
* Annualized
Total Return Ranking - Calendar
| Period | FMPCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | -22.3% | -98.2% | 781.7% | 88.31% |
| 2022 | 22.8% | -63.0% | 340.3% | 72.42% |
| 2021 | 28.6% | -9.1% | 48.3% | 21.01% |
| 2020 | -6.8% | -76.3% | 14.5% | 31.17% |
| 2019 | 16.0% | -8.4% | 42.0% | 74.70% |
NAV & Total Return History
FMPCX - Holdings
Concentration Analysis
| FMPCX | Category Low | Category High | FMPCX % Rank | |
|---|---|---|---|---|
| Net Assets | 185 M | 183 K | 28 B | 70.53% |
| Number of Holdings | 79 | 6 | 1336 | 68.03% |
| Net Assets in Top 10 | 57.3 M | 59 K | 2.7 B | 66.30% |
| Weighting of Top 10 | 19.95% | 4.7% | 100.0% | 66.19% |
Top 10 Holdings
- Horizon Therapeutics PLC 2.43%
- Horizon Therapeutics PLC 2.43%
- Horizon Therapeutics PLC 2.43%
- Horizon Therapeutics PLC 2.43%
- Horizon Therapeutics PLC 2.43%
- Horizon Therapeutics PLC 2.43%
- Horizon Therapeutics PLC 2.43%
- Horizon Therapeutics PLC 2.43%
- Horizon Therapeutics PLC 2.43%
- Horizon Therapeutics PLC 2.43%
Asset Allocation
| Weighting | Return Low | Return High | FMPCX % Rank | |
|---|---|---|---|---|
| Stocks | 98.00% | 77.52% | 101.30% | 41.54% |
| Cash | 2.00% | -1.30% | 22.49% | 51.88% |
| Preferred Stocks | 0.00% | 0.00% | 3.43% | 13.32% |
| Other | 0.00% | -1.57% | 20.21% | 28.68% |
| Convertible Bonds | 0.00% | 0.00% | 1.57% | 10.66% |
| Bonds | 0.00% | 0.00% | 3.19% | 9.87% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | FMPCX % Rank | |
|---|---|---|---|---|
| Technology | 26.72% | 0.00% | 75.51% | 38.24% |
| Healthcare | 25.08% | 0.00% | 58.05% | 31.35% |
| Industrials | 17.33% | 0.00% | 36.64% | 44.67% |
| Consumer Cyclical | 11.99% | 0.00% | 40.68% | 53.92% |
| Financial Services | 5.09% | 0.00% | 100.00% | 69.59% |
| Energy | 3.93% | 0.00% | 55.49% | 28.06% |
| Consumer Defense | 3.83% | 0.00% | 30.87% | 48.28% |
| Real Estate | 2.67% | 0.00% | 27.01% | 42.48% |
| Basic Materials | 2.10% | 0.00% | 11.17% | 58.46% |
| Communication Services | 1.25% | 0.00% | 15.31% | 67.55% |
| Utilities | 0.00% | 0.00% | 10.26% | 39.03% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | FMPCX % Rank | |
|---|---|---|---|---|
| US | 96.84% | 32.04% | 99.56% | 18.65% |
| Non US | 1.16% | 0.00% | 46.32% | 82.92% |
FMPCX - Expenses
Operational Fees
| FMPCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.96% | 0.03% | 6.02% | 8.35% |
| Management Fee | 0.81% | 0.05% | 4.05% | 53.85% |
| 12b-1 Fee | 1.00% | 0.00% | 1.00% | 83.93% |
| Administrative Fee | N/A | 0.01% | 0.40% | N/A |
Sales Fees
| FMPCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | 1.00% | 1.00% | 5.50% | 14.29% |
Trading Fees
| FMPCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| FMPCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 97.00% | 0.00% | 461.00% | 72.50% |
FMPCX - Distributions
Dividend Yield Analysis
| FMPCX | Category Low | Category High | FMPCX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 22.11% | 13.25% |
Dividend Distribution Analysis
| FMPCX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Annually | Quarterly | Annually |
Net Income Ratio Analysis
| FMPCX | Category Low | Category High | FMPCX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -1.62% | -5.42% | 1.10% | 92.83% |
Capital Gain Distribution Analysis
| FMPCX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
FMPCX - Fund Manager Analysis
Managers
Jon Loth
Start Date
Tenure
Tenure Rank
Oct 31, 2007
14.59
14.6%
JON A. LOTH, CFA Jon is the co-manager of the Small Cap Growth Opportunities Strategy and related institutional portfolios. He joined the team managing Small Cap Growth Opportunities in 2007. He previously was an equity research analyst covering the healthcare sector for the same team. Jon began working in the financial industry in 1994. Prior to joining the firm in 2004, he was an equity analyst covering healthcare and consumer-oriented stocks for large-, mid- and small-cap growth portfolios at Sit Investment Associates. Jon also served four years as the manager of Sit Investment’s domestic equity trading desk. He received a B.S. in finance from the University of Minnesota’s Carlson School of Management. Jon holds the Chartered Financial Analyst designation and is a member of the CFA Institute and the CFA Society of Minnesota.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.08 | 30.44 | 8.82 | 0.33 |